PTCT

Conviction 55HealthcareScan · Mon, Aug 10, 2026

PTCT$74.65+1.82%

ResistanceSupportVol 14Insider sell

Vol MA14 1.4M

May 11May 28Jun 16Jul 6Jul 23Aug 10

PTC THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.ptcbio.com ↗

Price74.65

Change+1.82%

Gap-0.83%

Rel volume1.00×

Avg volume1.36M

Avg $ vol100.71M

SMA 2074.93

SMA 5077.27

SMA 20073.23

Price vs 50-3.39%

Price vs 200+1.94%

MA stackmixed

50/200 cross—

Supertrenddown · 78.65

RSI (14)48

MACD hist-0.22

MACD cross—

Stoch %K / %D67 / 54

ADX (14)24

+DI / −DI21 / 26

RSI divergence—

MACD divergenceBearish

ATR %+4.25%

ADR %3.92%

52w high89.55

52w low43.30

From 52w high-16.64%

Above 52w low+72.39%

New 52w highNo

SqueezeOff

Bollinger width20.10%

%B0.48

Donchian pos60.19%

Donchian high81.31

Donchian low64.57

AVWAP (52w high)75.45

vs AVWAP high-1.07%

AVWAP (52w low)71.79

vs AVWAP low+3.98%

OBV trendFlat

Chaikin MF (20)-0.00

Today vs 20d1.00×

Avg vol (14d)1.4M

Avg vol (20d)1.36M

Avg $ vol (20d)100.71M

Market cap6.23B

RS 3m (vs SPY)+7.98%

RS 6m (vs SPY)-12.80%

RS line new highNo

Trend template5/8

Technical rank38.6

1 week+9.59%

1 month-12.03%

3 months+1.30%

6 months-0.05%

1 year+48.22%

YTD-2.73%

P/E9.13

P/B-37.67

P/S3.60

P/FCF8.87

EPS7.78

Div yield—

ROE-412.82%

ROA21.00%

Debt/Eq-3.57

Current3.39

EV/EBITDA6.37

Gross margin—

Net margin39.44%

Rev growth114.51%

EPS growth287.90%

Price target98.64

Target upside32.15%

Analyst ratingBuy

Institutional126.53%

Ent. value5.77B

Revenue360.52M

Net income83.5M

Gross profit—

Free cash flow702.34M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees991

ListedThu, Jun 20, 2013

Free float75.53M

Float %94.1%

Short interest9.83M

Days to cover4.8d

Short volume66.0%

Squeeze score67 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.92 vs −$0.17

Last surprise+641.2% beat

Setup gradeC

Conviction55 / 100

Pattern quality—

Tech rank38.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance88.95

Support68.59

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PTCT

All disclosures →

No recent disclosed trades by Congress in PTCT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PTCT · 3 buys · 7 sells

Insider	Side	Shares	Value	Traded	Filed
Gravier Pierre CHIEF FINANCIAL OFFICER · Common Stock · 2026-07-14	Sell	3.49K	$281K	2026-07-14	2026-07-16
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER · Common Stock · 2026-07-09	Exercise	2.46K	$115K	2026-07-09	2026-07-13
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER · Common Stock · 2026-07-09	Sell	2.46K	$222K	2026-07-09	2026-07-13
Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER · Stock Option (Right to Buy) · 2026-07-09	Exercise	2.46K	—	2026-07-09	2026-07-13
Smith Mary L. Director · Common Stock · 2026-07-09	Exercise	10K	$430K	2026-07-09	2026-07-13
Smith Mary L. Director · Common Stock · 2026-07-09	Sell	10K	$900K	2026-07-09	2026-07-13
Smith Mary L. Director · Common Stock · 2026-07-09	Exercise	5.83K	$251K	2026-07-09	2026-07-13
Smith Mary L. Director · Common Stock · 2026-07-09	Sell	5.83K	$525K	2026-07-09	2026-07-13
Smith Mary L. Director · Stock Option (Right to Buy) · 2026-07-09	Exercise	10K	—	2026-07-09	2026-07-13
Smith Mary L. Director · Stock Option (Right to Buy) · 2026-07-09	Exercise	5.83K	—	2026-07-09	2026-07-13

SEC filings

EDGAR filings in PTCT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.